Key result
Early OAC initiation fails to reduce recurrent ischemic stroke versus late initiation in AF.
Why the study?
Although oral anticoagulants reduce stroke risk in AF, the optimal timing for starting them after acute ischemic stroke remains uncertain, with varying recommendations across guidelines.
Does early initiation of oral anticoagulants reduce recurrent ischemic stroke compared to late initiation in adults with atrial fibrillation and recent ischemic stroke?
Meta-Analysis (n=6,522)
Does early initiation of oral anticoagulants reduce recurrent ischemic stroke compared to late initiation in adults with atrial fibrillation and recent ischemic stroke?
Relative Risk: 0.82 (95% CI 0.61–1.11)
p-value: p=0.19
Early initiation of oral anticoagulants after acute ischemic stroke in patients with atrial fibrillation appears to be as safe as late initiation, without increasing the risk of bleeding or mortality.
No difference in recurrent ischemic stroke with early versus late OAC; leaves open optimal timing and other safety endpoints.
Background Atrial fibrillation (AF) occurs in about 20% of ischemic stroke cases. Although oral anticoagulants (OACs) reduce stroke risk in AF, the optimal timing for starting them after acute ischemic stroke remains uncertain, with varying recommendations across guidelines.Methods A systematic review and meta-analysis of randomized controlled trials was conducted using PubMed, Scopus, Web of Science, EMBASE, and Cochrane CENTRAL through October 2024. Studies included adults with AF and recent ischemic stroke, comparing early versus late OAC initiation. The primary outcome was recurrent ischemic stroke. Risk of bias was assessed using the Cochrane RoB2 tool.Results Three trials with 6522 patients were included. There were no significant differences between early and late OAC initiation in recurrent ischemic stroke (relative risk [RR] 0.82; 95% confidence interval [CI] 0.61–1.11; P = 0.19), major extracranial bleeding (RR 0.47; 95% CI 0.22–1.01; P = 0.05), intracranial hemorrhage (RR 0.93; 95% CI 0.44–1.96; P = 0.84), or mortality (RR 0.79; 95% CI 0.50–1.24; P = 0.30).Conclusion Early OAC initiation after ischemic stroke in AF appears as safe as later initiation, without higher bleeding or mortality risks. Given the elevated risk of early recurrence, prompt anticoagulation may be beneficial but requires further confirmation.
No takes yet. Share an insight, caveat, or question.
Manasrah et al. (2026) conducted a meta-analysis in Atrial fibrillation and recent ischemic stroke (n=6,522). Early oral anticoagulant initiation vs. Late oral anticoagulant initiation was evaluated on Recurrent ischemic stroke (RR 0.82, 95% CI 0.61-1.11, p=0.19). Early oral anticoagulant initiation after ischemic stroke in atrial fibrillation did not significantly reduce recurrent ischemic stroke compared to late initiation (RR 0.82; 95% CI 0.61-1.11; P=0.19).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: